171 related articles for article (PubMed ID: 2921115)
1. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
Ehring F
Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
[TBL] [Abstract][Full Text] [Related]
2. [Diffuse melanosis with generalized and ocular metastasis in malignant melanoma].
Ring J; Emslander C
Hautarzt; 1984 Jun; 35(6):308-12. PubMed ID: 6469636
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma of the skin].
Simon JC; Grimme H; Bergen E; Vanscheidt W; Schöpf E
Fortschr Med; 1995 Oct; 113(28):393-6. PubMed ID: 7498864
[TBL] [Abstract][Full Text] [Related]
6. Thin malignant melanomas with regression and metastases.
Ronan SG; Eng AM; Briele HA; Shioura NN; Das Gupta TK
Arch Dermatol; 1987 Oct; 123(10):1326-30. PubMed ID: 3662564
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
Denisov LE; Kurdina MI
Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
[TBL] [Abstract][Full Text] [Related]
9. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
[TBL] [Abstract][Full Text] [Related]
10. Determinants of outcome in melanoma patients with cerebral metastases.
Fife KM; Colman MH; Stevens GN; Firth IC; Moon D; Shannon KF; Harman R; Petersen-Schaefer K; Zacest AC; Besser M; Milton GW; McCarthy WH; Thompson JF
J Clin Oncol; 2004 Apr; 22(7):1293-300. PubMed ID: 15051777
[TBL] [Abstract][Full Text] [Related]
11. [Five years survival after treatment of gallbladder metastasis of malignant melanoma].
Bugnon PY; Servais B; Boulenger-Bugnon P; Gautier-Benoît C
Bull Cancer; 1991; 78(2):169-72. PubMed ID: 2036487
[TBL] [Abstract][Full Text] [Related]
12. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
[No Abstract] [Full Text] [Related]
13. [Malignant melanoma].
Champeau F; Verola O
Ann Chir Plast Esthet; 1998 Aug; 43(4):411-20. PubMed ID: 9926473
[TBL] [Abstract][Full Text] [Related]
14. [Malignant melanoma of the skin: current diagnostic and therapeutic approaches].
Melita P; Barbuscia M; Calbo L; Belnome NA; Palmeri R; Lazzara S; Lorenzini C
Chir Ital; 1989; 41(4-6):167-79. PubMed ID: 2701737
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma metastatic to the ovary.
Piura B; Kedar I; Ariad S; Meirovitz M; Yanai-Inbar I
Gynecol Oncol; 1998 Feb; 68(2):201-5. PubMed ID: 9514807
[TBL] [Abstract][Full Text] [Related]
16. Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study.
Reali UM; Martini L; Borgognoni L; Semino C; Pietra G; Chiarugi C; Guastella M; Melioli G
Melanoma Res; 1998 Feb; 8(1):77-82. PubMed ID: 9508381
[TBL] [Abstract][Full Text] [Related]
17. [Primary multiple malignant melanomas of unusually long duration].
Korsch A; Gartmann H; Steigleder GK
Z Hautkr; 1976 Nov; 51(22):949-56. PubMed ID: 1007359
[TBL] [Abstract][Full Text] [Related]
18. [Comment on the contribution by F. Ehring: Regression of over 150 skin metastases of malignant melanoma by homeopathic complex therapy].
Grond K
Hautarzt; 1989 Jul; 40(7):464. PubMed ID: 2759865
[No Abstract] [Full Text] [Related]
19. [Regression of melanoma metastases after immunological therapy].
Malek-Mansour S; Castermans-Elias S; Lapière CM
Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
[No Abstract] [Full Text] [Related]
20. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
